Alpha-Difluoromethylornithine (Dfmo) Use In The Human Prostate


Ontology type: sgo:Patent     


Patent Info

DATE

2003-07-31T00:00

AUTHORS

GERNER EUGENE W , MEYSKENS FRANK L JR , SIMONEAU ANNE R

ABSTRACT

The present invention concerns a method for treating and/or inhibiting prostate cancer in a patient comprising administering α-difluoromethylornithine (DFMO) in an amount and duration sufficient to stabilize or reduce the amount of polyamine produced by the hyperplastic cells, wherein said polyamine is spermine, spermidine or a combination of spermine and spermidine. Methods of administration, dosing, and combinational therapies are described. More... »

Related SciGraph Publications

  • 2000-12. Polyamine depletion therapy in prostate cancer in PROSTATE CANCER AND PROSTATIC DISEASES
  • JSON-LD is the canonical representation for SciGraph data.

    TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

    [
      {
        "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
        "about": [
          {
            "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/3142", 
            "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
            "type": "DefinedTerm"
          }
        ], 
        "author": [
          {
            "name": "GERNER EUGENE W", 
            "type": "Person"
          }, 
          {
            "name": "MEYSKENS FRANK L JR", 
            "type": "Person"
          }, 
          {
            "name": "SIMONEAU ANNE R", 
            "type": "Person"
          }
        ], 
        "citation": [
          {
            "id": "sg:pub.10.1038/sj.pcan.4500420", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1011980478", 
              "https://doi.org/10.1038/sj.pcan.4500420"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.1093/jnci/86.15.1122", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1059818753"
            ], 
            "type": "CreativeWork"
          }
        ], 
        "datePublished": "2003-07-31T00:00", 
        "description": "

    The present invention concerns a method for treating and/or inhibiting prostate cancer in a patient comprising administering α-difluoromethylornithine (DFMO) in an amount and duration sufficient to stabilize or reduce the amount of polyamine produced by the hyperplastic cells, wherein said polyamine is spermine, spermidine or a combination of spermine and spermidine. Methods of administration, dosing, and combinational therapies are described.

    ", "id": "sg:patent.WO-2002015895-A3", "keywords": [ "Eflornithine", "DFMO", "human prostate", "invention", "prostate cancer patient", "duration", "polyamines", "cell", "wherein", "spermine", "spermidine", "method", "Organization and Administration", "dosing", "combinational therapy" ], "name": "ALPHA-DIFLUOROMETHYLORNITHINE (DFMO) USE IN THE HUMAN PROSTATE", "recipient": [ { "id": "https://www.grid.ac/institutes/grid.30389.31", "type": "Organization" }, { "id": "https://www.grid.ac/institutes/grid.134563.6", "type": "Organization" } ], "sameAs": [ "https://app.dimensions.ai/details/patent/WO-2002015895-A3" ], "sdDataset": "patents", "sdDatePublished": "2019-04-18T10:30", "sdLicense": "https://scigraph.springernature.com/explorer/license/", "sdPublisher": { "name": "Springer Nature - SN SciGraph project", "type": "Organization" }, "sdSource": "s3://com-uberresearch-data-patents-target-20190320-rc/data/sn-export/402f166718b70575fb5d4ffe01f064d1/0000100128-0000352499/json_export_03396.jsonl", "type": "Patent" } ]
     

    Download the RDF metadata as:  json-ld nt turtle xml License info

    HOW TO GET THIS DATA PROGRAMMATICALLY:

    JSON-LD is a popular format for linked data which is fully compatible with JSON.

    curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/patent.WO-2002015895-A3'

    N-Triples is a line-based linked data format ideal for batch operations.

    curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/patent.WO-2002015895-A3'

    Turtle is a human-readable linked data format.

    curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/patent.WO-2002015895-A3'

    RDF/XML is a standard XML format for linked data.

    curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/patent.WO-2002015895-A3'


     

    This table displays all metadata directly associated to this object as RDF triples.

    54 TRIPLES      15 PREDICATES      32 URIs      23 LITERALS      2 BLANK NODES

    Subject Predicate Object
    1 sg:patent.WO-2002015895-A3 schema:about anzsrc-for:3142
    2 schema:author N1b6069cd945748d7812c0688ca1b860c
    3 schema:citation sg:pub.10.1038/sj.pcan.4500420
    4 https://doi.org/10.1093/jnci/86.15.1122
    5 schema:datePublished 2003-07-31T00:00
    6 schema:description <p>The present invention concerns a method for treating and/or inhibiting prostate cancer in a patient comprising administering &#945;-difluoromethylornithine (DFMO) in an amount and duration sufficient to stabilize or reduce the amount of polyamine produced by the hyperplastic cells, wherein said polyamine is spermine, spermidine or a combination of spermine and spermidine. Methods of administration, dosing, and combinational therapies are described.</p>
    7 schema:keywords DFMO
    8 Eflornithine
    9 Organization and Administration
    10 cell
    11 combinational therapy
    12 dosing
    13 duration
    14 human prostate
    15 invention
    16 method
    17 polyamines
    18 prostate cancer patient
    19 spermidine
    20 spermine
    21 wherein
    22 schema:name ALPHA-DIFLUOROMETHYLORNITHINE (DFMO) USE IN THE HUMAN PROSTATE
    23 schema:recipient https://www.grid.ac/institutes/grid.134563.6
    24 https://www.grid.ac/institutes/grid.30389.31
    25 schema:sameAs https://app.dimensions.ai/details/patent/WO-2002015895-A3
    26 schema:sdDatePublished 2019-04-18T10:30
    27 schema:sdLicense https://scigraph.springernature.com/explorer/license/
    28 schema:sdPublisher N7ebe45da54c54ca2a9bbd88a73195d68
    29 sgo:license sg:explorer/license/
    30 sgo:sdDataset patents
    31 rdf:type sgo:Patent
    32 N1b6069cd945748d7812c0688ca1b860c rdf:first Nb37716aa28314ac59955bce08c8eb2e9
    33 rdf:rest N2d75a9568a8d47079a070f7779d9ebf1
    34 N2d75a9568a8d47079a070f7779d9ebf1 rdf:first N2f259fef114b425a9922fc458ecc9ee7
    35 rdf:rest Nd550e80bcee54bf6bc29d80bec8bdcbb
    36 N2f259fef114b425a9922fc458ecc9ee7 schema:name MEYSKENS FRANK L JR
    37 rdf:type schema:Person
    38 N7ebe45da54c54ca2a9bbd88a73195d68 schema:name Springer Nature - SN SciGraph project
    39 rdf:type schema:Organization
    40 N8951b0566f01493fbae0d56ea34de77b schema:name SIMONEAU ANNE R
    41 rdf:type schema:Person
    42 Nb37716aa28314ac59955bce08c8eb2e9 schema:name GERNER EUGENE W
    43 rdf:type schema:Person
    44 Nd550e80bcee54bf6bc29d80bec8bdcbb rdf:first N8951b0566f01493fbae0d56ea34de77b
    45 rdf:rest rdf:nil
    46 anzsrc-for:3142 schema:inDefinedTermSet anzsrc-for:
    47 rdf:type schema:DefinedTerm
    48 sg:pub.10.1038/sj.pcan.4500420 schema:sameAs https://app.dimensions.ai/details/publication/pub.1011980478
    49 https://doi.org/10.1038/sj.pcan.4500420
    50 rdf:type schema:CreativeWork
    51 https://doi.org/10.1093/jnci/86.15.1122 schema:sameAs https://app.dimensions.ai/details/publication/pub.1059818753
    52 rdf:type schema:CreativeWork
    53 https://www.grid.ac/institutes/grid.134563.6 schema:Organization
    54 https://www.grid.ac/institutes/grid.30389.31 schema:Organization
     




    Preview window. Press ESC to close (or click here)


    ...